药物诱导的免疫性溶血性贫血:全国队列研究中新信号检测与风险评估
研究旨在检测药物诱导免疫性溶血性贫血(DIIHA)的新信号并评估疑似药物与免疫性溶血性贫血发生的关联。利用Vigibase数据库进行不成比例分析发现3371例DIIHA并识别59个新信号,最终112种在法国上市的药物纳入全国队列分析(4746例患者匹配22447例对照)。病例对照和病例交叉设计显示免疫性溶血性贫血发生与某些抗生素、抗真菌药、布洛芬、对乙酰氨基酚、呋塞米、硫唑嘌呤和碘美普尔存在关联。
要点
- Vigibase数据库中共记录3371例DIIHA病例,识别出59个新信号。
- 最终112种药物纳入全国队列分析,包括4746例患者和22447例对照。
- 免疫性溶血性贫血与某些抗生素、抗真菌药、布洛芬、对乙酰氨基酚、呋塞米、硫唑嘌呤和碘美普尔存在关联。
核心结论
- 免疫性溶血性贫血的发生与某些抗生素、抗真菌药、布洛芬、对乙酰氨基酚、呋塞米、硫唑嘌呤和碘美普尔存在关联。
研究设计与样本
- 病例对照分析纳入4746例免疫性溶血性贫血患者,匹配22447例来自一般人群的对照。
主要发现
- Vigibase中记录3371例DIIHA病例。
- 识别出59个新信号,最终112种在法国上市的药物纳入全国队列分析。
- 免疫性溶血性贫血的发生与某些抗生素、抗真菌药、布洛芬、对乙酰氨基酚、呋塞米、硫唑嘌呤和碘美普尔存在关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
More than 130 drugs have been suspected to induce immune hemolytic anemia. Comparative studies measuring the risk of drug-induced immune hemolytic anemia (DIIHA) are lacking. We aimed (1) to detect new signals of DIIHA, excluding vaccines, and (2) to assess the association between all suspected drugs and the occurrence of immune hemolytic anemia in a nationwide comparative study. The new signals were identified using a disproportionality study (case/noncase design) in the World Pharmacovigilance Database, Vigibase, among the cases of adverse drug reactions reported up to February 2020 (>20 million). We then conducted a comparative study in the French National health database that links sociodemographic, out-of-hospital, and hospital data for the entire population (67 million individuals). Associations between exposure to drugs (those already reported as DIIHA, plus new signals identified in Vigibase) and incident cases of immune hemolytic anemia (D59.0 and D59.1 diagnosis codes of the International Classification of Diseases, version 10) from 2012 to 2018 were assessed with case-control and case-crossover designs. In Vigibase, 3371 cases of DIIHA were recorded. Fifty-nine new signals were identified resulting in a final list of 112 drugs marketed in France and measurable in the nationwide cohort (n = 4746 patients with incident immune hemolytic anemia included in the case-control analysis matched with 22 447 controls from the general population). We identified an association between immune hemolytic anemia occurrence and some antibiotics, antifungal drugs, ibuprofen, acetaminophen, furosemide, azathioprine, and iomeprol.
引用
- Maquet J, Lafaurie M, Michel M, et al. Drug-induced immune hemolytic anemia: detection of new signals and risk assessment in a nationwide cohort study. Blood Adv. 2024. PMID: 37782770. doi:10.1182/bloodadvances.2023009801
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。